Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Citi
AstraZeneca
Daiichi Sankyo
Fuji
McKinsey
Mallinckrodt

Generated: August 22, 2019

DrugPatentWatch Database Preview

Patent: 8,901,086

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,901,086
Title:Compositions including triciribine and methods of use thereof
Abstract: This invention encompasses combination therapies including TCN, TCN-P, TCN-PM and/or related compounds and one or more additional anti-cancer agents, for example, taxanes a molecule that modulates the HER2/neu (erbB2) receptor, anthracyclin compounds, epidermal growth factor receptor inhibitor compounds, one or more platinum compounds and bortezomib and derivatives thereof and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.
Inventor(s): Cheng; Jin Q. (Tampa, FL), Sebti; Said M. (Tampa, FL)
Assignee: University of South Florida (Tampa, FL)
Application Number:13/463,576
Patent Claims:see list of patent claims

Details for Patent 8,901,086

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25 ➤ Sign Up University of South Florida (Tampa, FL) 2025-03-29 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 8,901,086

Country Patent Number Publication Date
World Intellectual Property Organization (WIPO) 2005094322 Dec 29, 2005
World Intellectual Property Organization (WIPO) 2005094322 Oct 13, 2005
World Intellectual Property Organization (WIPO) 2009139766 Nov 19, 2009
United States of America 2006247188 Nov 02, 2006
United States of America 2010009928 Jan 14, 2010
United States of America 2010009929 Jan 14, 2010
United States of America 2010028339 Feb 04, 2010
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Fuji
UBS
Deloitte
McKesson
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.